» Articles » PMID: 35288606

A Novel Hybrid Peptide Composed of LfcinB6 and KR-12-a4 with Enhanced Antimicrobial, Anti-inflammatory and Anti-biofilm Activities

Overview
Journal Sci Rep
Specialty Science
Date 2022 Mar 15
PMID 35288606
Authors
Affiliations
Soon will be listed here.
Abstract

Hybridizing two known antimicrobial peptides (AMPs) is a simple and effective strategy for designing antimicrobial agents with enhanced cell selectivity against bacterial cells. Here, we generated a hybrid peptide Lf-KR in which LfcinB6 and KR-12-a4 were linked with a Pro hinge to obtain a novel AMP with potent antimicrobial, anti-inflammatory, and anti-biofilm activities. Lf-KR exerted superior cell selectivity for bacterial cells over sheep red blood cells. Lf-KR showed broad-spectrum antimicrobial activities (MIC: 4-8 μM) against tested 12 bacterial strains and retained its antimicrobial activity in the presence of salts at physiological concentrations. Membrane depolarization and dye leakage assays showed that the enhanced antimicrobial activity of Lf-KR was due to increased permeabilization and depolarization of microbial membranes. Lf-KR significantly inhibited the expression and production of pro-inflammatory cytokines (nitric oxide and tumor necrosis factor-α) in LPS-stimulated mouse macrophage RAW264.7 cells. In addition, Lf-KR showed a powerful eradication effect on preformed multidrug-resistant Pseudomonas aeruginosa (MDRPA) biofilms. We confirmed using confocal laser scanning microscopy that a large portion of the preformed MDRPA biofilm structure was perturbed by the addition of Lf-KR. Collectively, our results suggest that Lf-KR can be an antimicrobial, anti-inflammatory, and anti-biofilm candidate as a pharmaceutical agent.

Citing Articles

Selective toxicity of a novel antimicrobial peptide Acidocin 4356 against Pseudomonas aeruginosa and Acinetobacter baumannii in human cell-based in vitro infection models.

Talaee M, Modiri S, Rajabi M, Saadati F, Akbari A, Javadi S Sci Rep. 2025; 15(1):2450.

PMID: 39828811 PMC: 11743754. DOI: 10.1038/s41598-025-86115-7.


Nanolevel Immunomodulators in Sepsis: Novel Roles, Current Perspectives, and Future Directions.

Lin L, Liu H, Zhang D, Du L, Zhang H Int J Nanomedicine. 2024; 19:12529-12556.

PMID: 39606559 PMC: 11600945. DOI: 10.2147/IJN.S496456.


Hybrids of Membrane-Translocating Antimicrobial Peptides Show Enhanced Activity through Membrane Permeabilization.

Trevellin G, Kwag J, Shui M, Klim H, Alvarez V, Darling L ACS Med Chem Lett. 2024; 15(11):1918-1924.

PMID: 39563817 PMC: 11571015. DOI: 10.1021/acsmedchemlett.4c00375.


Antibacterial and antibiofilm features of SMAP-18 against .

Jahan I, Ganbaatar B, Lee C, Shin S, Yang S Heliyon. 2024; 10(21):e40108.

PMID: 39559243 PMC: 11570489. DOI: 10.1016/j.heliyon.2024.e40108.


Origami of KR-12 Designed Antimicrobial Peptides and Their Potential Applications.

Lakshmaiah Narayana J, Mechesso A, Rather I, Zarena D, Luo J, Xie J Antibiotics (Basel). 2024; 13(9).

PMID: 39334990 PMC: 11429261. DOI: 10.3390/antibiotics13090816.


References
1.
Rossolini G, Arena F, Pecile P, Pollini S . Update on the antibiotic resistance crisis. Curr Opin Pharmacol. 2014; 18:56-60. DOI: 10.1016/j.coph.2014.09.006. View

2.
Pasupuleti M, Schmidtchen A, Malmsten M . Antimicrobial peptides: key components of the innate immune system. Crit Rev Biotechnol. 2011; 32(2):143-71. DOI: 10.3109/07388551.2011.594423. View

3.
Andreu D, Ubach J, Boman A, Wahlin B, Wade D, MERRIFIELD R . Shortened cecropin A-melittin hybrids. Significant size reduction retains potent antibiotic activity. FEBS Lett. 1992; 296(2):190-4. DOI: 10.1016/0014-5793(92)80377-s. View

4.
Boman H, Wade D, Boman I, Wahlin B, MERRIFIELD R . Antibacterial and antimalarial properties of peptides that are cecropin-melittin hybrids. FEBS Lett. 1989; 259(1):103-6. DOI: 10.1016/0014-5793(89)81505-4. View

6.
Dong N, Li X, Xu X, Lv Y, Li Z, Shan A . Characterization of bactericidal efficiency, cell selectivity, and mechanism of short interspecific hybrid peptides. Amino Acids. 2017; 50(3-4):453-468. DOI: 10.1007/s00726-017-2531-1. View